CYH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $2.72
Capitalización Bursátil (MRQ) $384M
P/E (TTM) 1.5
BPA (TTM) $1.86
Ingresos (TTM) $11.98B
ROE (TTM) -16.7%
Deuda/Capital (MRQ) -6.9
Rango 52S $2–$4

CYH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Divisiones de acciones 1
Fecha ex-dividendo División Tipo
22 de abril de 2016 121-for-100 Adelante

Acerca de Community Health Systems, Inc. Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealth Care industriaHealth Care empleados44 000 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$12.48B
2016-12-31 → 2025-12-31
BPA$3.77
2016-12-31 → 2025-12-31
Flujo de caja libre$208M
2016-12-31 → 2025-12-31
Margen neto2.1%
2018-12-31 → 2025-12-31
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años CYH promedio 5A Mediana de Pares Veredicto
P/E (TTM) 1.5promedio 5A ≈3.4 ≈3.4 15.5 Infravalorado
P/S (TTM) 0.0promedio 5A ≈0.1 ≈0.1 1.2 Infravalorado
P/C (MRQ) -0.3promedio 5A ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.1promedio 5A ≈13.1 ≈13.1 10.6 Infravalorado
Precio / FCF (TTM) -2.1promedio 5A ≈-0.8 ≈-0.8 · ·
Precio / Flujo de Caja (TTM) 3.0promedio 5A ≈-1.6 ≈-1.6 6.5 Infravalorado
EV / Revenue (EV / Ingresos) 0.8promedio 5A ≈1.0 ≈1.0 · ·
EV / FCF 50.5promedio 5A ≈-4.9 ≈-4.9 · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

13
Fecha ex-dividendoMontoMonedaRendimiento
Dic 13, 2012$0,21USD≈0.84%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media 37.9%
Próximo informe Oct 21, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Jul 21, 2026 $-0.19 $-0.06 -201.1%
31 de marzo de 2026 $-0.48 $-0.10 -387.3%
31 de diciembre de 2025 $-0.01 $-0.10 90.5%
30 de septiembre de 2025 $1.27 $-0.25 610.5%
30 de junio de 2025 $-0.05 $-0.11 52.6%
31 de marzo de 2025 $-0.03 $-0.08 62.6%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 13
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Balance general 26
Métrica Tendencia 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Flujo de Efectivo 13
Métrica Tendencia 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Rentabilidad 7
Métrica Tendencia 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Liquidez y Solvencia 4
Métrica Tendencia 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Eficiencia 2
Métrica Tendencia 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Por Acción 5
Métrica Tendencia 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Tasas de Crecimiento 9
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Valoración (TTM) 13
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $12.48B $12.63B $12.49B $12.21B $12.37B
Margen Operativo % 11.9% 4.3% 7.7% 6.7% 11.3%
Beneficio neto $509M $-516M $-133M $46M $230M
EPS Diluido $3.77 $-3.90 $-1.02 $0.35 $1.76

Propietarios institucionales (13F) 196 declarantes · $415.1M total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 196
Valor en tenencia $415.1M
Nuevas posiciones 31
Posiciones cerradas 24
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
31 (+9 vs trimestre anterior) 24 (+4 vs trimestre anterior) 69 (+6 vs trimestre anterior) 54 (-9 vs trimestre anterior) +7.0M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
CastleKnight Management LP $44 704 517 13 384 586 10,77% Acciones
Apollo Management Holdings, L.P. $39 610 817 11 859 526 9,54% Acciones
BlackRock, Inc. $36 507 995 10 930 538 8,79% Acciones
VANGUARD GROUP INC $28 605 579 9 168 455 6,89% Acciones
Eversept Partners, LP $26 267 680 7 864 575 6,33% Acciones
NOMURA HOLDINGS INC $22 388 384 6 703 109 5,39% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $17 668 370 5 289 931 4,26% Acciones
WHITEBOX ADVISORS LLC $12 467 362 3 732 743 3,00% Acciones
GEODE CAPITAL MANAGEMENT, LLC $10 582 352 3 167 702 2,55% Acciones
STATE STREET CORP $10 226 622 3 061 863 2,46% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $10 082 117 3 018 598 2,43% Acciones
Saba Capital Management, L.P. $9 626 444 2 882 169 2,32% Acciones
Owl Creek Asset Management, L.P. $8 452 277 2 530 622 2,04% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8 176 380 2 448 018 1,97% Acciones
DIMENSIONAL FUND ADVISORS LP $7 854 253 2 351 460 1,89% Acciones
D. E. Shaw & Co., Inc. $7 829 388 2 344 128 1,89% Acciones
AQR CAPITAL MANAGEMENT LLC $7 651 362 2 290 827 1,84% Acciones
TWO SIGMA INVESTMENTS, LP $7 365 822 2 205 336 1,77% Acciones
Diameter Capital Partners LP $6 138 793 1 837 962 1,48% Acciones
BANK OF AMERICA CORP /DE/ $5 903 847 1 767 619 1,42% Acciones
GOLDMAN SACHS GROUP INC $5 868 073 1 756 908 1,41% Acciones
TWO SIGMA ADVISERS, LP $5 816 476 1 864 255 1,40% Acciones
CARRONADE CAPITAL MANAGEMENT, LP $5 230 000 1 565 847 1,26% Acciones
Allianz Asset Management GmbH $5 167 919 1 547 281 1,24% Acciones
MORGAN STANLEY $4 800 489 1 437 272 1,16% Acciones
NORTHERN TRUST CORP $4 681 414 1 401 621 1,13% Acciones
Silver Rock Financial LP $3 674 000 1 100 000 0,89% Acciones
CITADEL ADVISORS LLC $3 475 360 1 040 527 0,84% Acciones
Assenagon Asset Management S.A. $2 788 275 834 813 0,67% Acciones
VANGUARD FIDUCIARY TRUST CO $2 642 231 791 087 0,64% Acciones
Jefferies Financial Group Inc. $2 481 286 742 900 0,60% Acciones
Alta Fundamental Advisers LLC $2 161 411 647 129 0,52% Acciones
Bank of New York Mellon Corp $2 122 084 635 354 0,51% Acciones
MARSHALL WACE, LLP $1 906 575 570 831 0,46% Acciones
MILLENNIUM MANAGEMENT LLC $1 701 580 509 455 0,41% Acciones
ExodusPoint Capital Management, LP $1 664 603 498 384 0,40% Acciones
READYSTATE ASSET MANAGEMENT LP $1 657 729 496 326 0,40% Acciones
WOLVERINE ASSET MANAGEMENT LLC $1 339 674 401 100 0,32% Opción de compra
Helix Partners Management LP $1 336 000 400 000 0,32% Acciones
Susquehanna Portfolio Strategies, LLC $1 280 940 383 515 0,31% Acciones
Voleon Capital Management LP $1 247 032 373 363 0,30% Acciones
Invesco Ltd. $1 076 599 322 335 0,26% Acciones
TUDOR INVESTMENT CORP ET AL $999 388 299 218 0,24% Acciones
Pathstone Holdings, LLC $895 621 268 150 0,22% Acciones
Prescott Group Capital Management, L.L.C. $863 076 258 406 0,21% Acciones
UBS Group AG $851 089 254 817 0,21% Acciones
MILLENNIUM MANAGEMENT LLC $835 000 250 000 0,20% Opción de venta
FEDERATED HERMES, INC. $812 599 243 293 0,20% Acciones
LPL Financial LLC $737 239 220 730 0,18% Acciones
IEQ CAPITAL, LLC $657 963 196 995 0,16% Acciones

Mostrar todos los 196 propietarios institucionales →

Activistas y propietarios del %+ 5 1 tenencia

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 presentaciones 11 de marzo de 2021 · Presentación inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 56 insiders · 29 directivos · 23 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Kevin J Hammons CEO 1 de marzo de 2026 A 895 545 0 0 $0
Tim Hingtgen CEO 1 de marzo de 2025 A 1 388 781 0 0 $0
Jason K Johnson EVP & CFO 1 de marzo de 2026 A 268 439 0 0 $0
Thomas J Aaron EVP and CFO 7 de diciembre de 2019 F 241 515 0 0 $0
Larry W Cash President and CFO 1 de marzo de 2017 A 568 152 0 0 $0
Miguel S Benet President and CMO 1 de marzo de 2025 D 47 635 0 0 $0
Austen D Mason Regional President 1 de marzo de 2025 A 142 500 0 0 $0
Mark B Medley Regional President 1 de marzo de 2025 A 128 637 0 0 $0
Chad A Campbell Regional President 1 de marzo de 2025 A 136 815 0 0 $0
Charles J Cova Regional President 1 de marzo de 2024 A 58 701 0 0 $0
Lynn T Simon President and CMO 1 de marzo de 2024 A 482 657 0 0 $0
Beryl Ramsey Division President 1 de marzo de 2019 A 62 969 0 0 $0
Patton Paul Smith Division President 1 de marzo de 2019 F 119 017 0 0 $0
Iii John W Mcclellan Division President 1 de marzo de 2017 A 41 242 0 0 $0
Robert O Horrar Division President 1 de marzo de 2017 A 68 649 0 0 $0
Martin Bonick Division President 1 de marzo de 2017 A 100 458 0 0 $0
Michael T Portacci Division President 1 de marzo de 2017 A 110 156 0 0 $0
Thomas Daniel Miller Division President 1 de marzo de 2016 A 112 107 0 0 $0
David Lewis Miller President and COO 1 de marzo de 2016 A 440 840 0 0 $0
William S Hussey Division President 28 de octubre de 2015 M 121 568 0 0 $0
Martin Dewayne Smith Division President 3 de junio de 2015 M 94 111 0 0 $0
Gary D Newsome Division President - Group Ops 25 de agosto de 2008 M 118 286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1 de junio de 2026 A 30 000 0 0 $0
Phillip A. Posey SVP & CAO 1 de marzo de 2026 A 51 736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1 de marzo de 2026 A 287 750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1 de marzo de 2026 A 208 290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1 de marzo de 2017 F 243 065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 de febrero de 2012 F 78 379 0 0 $0
Martin G Schweinhart Senior Vice President 1 de marzo de 2006 A 40 354 0 0 $0
William Norris Jennings Consejero 25 de agosto de 2026 S 38 468 0 1 $-118 400
Ranga K Krishnan Consejero 30 de junio de 2026 M 170 023 0 0 $0
Fawn D Lopez Consejero 1 de marzo de 2026 A · 0 0 $0
Ronald L Burgess JR Consejero 1 de marzo de 2026 A · 0 0 $0
Susan W Brooks Consejero 1 de marzo de 2026 A 108 695 0 0 $0
Hubert James Williams Consejero 1 de marzo de 2026 A 211 863 0 0 $0
Joseph Arthur Hastings Consejero 1 de marzo de 2026 A 0 0 0 $0
Elizabeth T Hirsch Consejero 1 de marzo de 2026 A 162 059 0 0 $0
James S. Ely III Consejero 1 de marzo de 2026 A 412 876 0 0 $0
John A Fry Consejero 1 de marzo de 2026 A 268 966 0 0 $0
John A Clerico Consejero 1 de marzo de 2026 A 368 763 0 0 $0
Michael Dinkins Consejero 1 de marzo de 2026 A 225 882 0 0 $0
Wayne T Smith Consejero 1 de marzo de 2026 A 5 217 579 0 0 $0
Julia B North Consejero 1 de marzo de 2021 A 162 056 0 0 $0
Mitchell H Watson JR Consejero 16 de mayo de 2017 M 22 594 0 0 $0
Harvey Klein MD Consejero 15 de marzo de 2010 M 10 383 0 0 $0
Dale F Frey Consejero 31 de marzo de 2008 A 20 000 0 0 $0
Thomas H Lister Consejero 21 de septiembre de 2004 S 0 0 0 $0
Thodore Forstmann Consejero 21 de septiembre de 2004 S 0 0 0 $0
Sandra Horbach Consejero 21 de septiembre de 2004 S 0 0 0 $0
Robert J Dole Consejero 6 de mayo de 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP Propietario del 10% 21 de septiembre de 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP Propietario del 10% 21 de septiembre de 2004 S 0 0 0 $0
Winston Hutchins Propietario del 10% 21 de septiembre de 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP Propietario del 10% 21 de septiembre de 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P Propietario del 10% 21 de septiembre de 2004 S 0 0 0 $0
Benjamin C Fordham · 1 de marzo de 2021 A 254 608 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 25 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
BSJR · Invesco Exchange-Traded Self-Indexe… 2,68% 23 297 000 1 de octubre de 2026 Diario
EBIT · Harbor ETF Trust 0,45% 19 210 NS 31 de julio de 2026 N-PORT
IWC · iShares Trust 0,09% 443 690 SH 11 de septiembre de 2026 Diario
IHF · iShares Trust 0,05% 223 947 SH 11 de septiembre de 2026 Diario
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113 109 SH 19 de agosto de 2026 Diario
NEAR · iShares U.S. ETF Trust 0,03% 1 340 000 SH 11 de septiembre de 2026 Diario
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 226 491 SH 1 de octubre de 2026 Diario
IWM · iShares Trust 0,01% 3 425 206 SH 11 de septiembre de 2026 Diario
RSSL · Global X Funds 0,01% 62 038 NS 31 de julio de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746 733 SH 19 de agosto de 2026 Diario
VHT · VANGUARD WORLD FUND 0,01% 349 881 SH 19 de agosto de 2026 Diario
DFAS · Dimensional ETF Trust 0,01% 289 348 NS 31 de julio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202 789 NS 31 de julio de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33 838 NS 31 de julio de 2026 N-PORT
ITOT · iShares Trust 0,00% 203 848 SH 11 de septiembre de 2026 Diario
IWV · iShares Trust 0,00% 42 177 SH 3 de septiembre de 2026 Diario
DCOR · Dimensional ETF Trust 0,00% 6 184 NS 31 de julio de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31 135 NS 31 de julio de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1 347 195 SH 19 de agosto de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,00% 3 813 888 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9 817 SH 19 de agosto de 2026 Diario
DFSU · Dimensional ETF Trust 0,00% 24 NS 31 de julio de 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 de julio de 2026 Diario
VPLS · VANGUARD MALVERN FUNDS · · 15 de julio de 2026 Diario
IWN · iShares Trust · 1 223 127 SH 11 de septiembre de 2026 Diario

CYH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 16 analistas MANTENER
Objetivo mediano $3.12 +14,9%
1 6,2% Compra fuerte
1 6,2% Compra
6 37,5% Mantener
7 43,8% Venta
1 6,2% Venta fuerte

Precio objetivo a 12 meses

8 analistas · 2026-10-01

Objetivo medio $3.16 +16,0%

Ahora Precio Actual $2.72
Mín$2.00 Media$3.16 Máx$4.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Jul 23, 2026